Clinicians now have an FDA-approved liquid desmopressin option for central diabetes insipidus, designed for dosing consistency across the age spectrum.
STATE COLLEGE, PENNSYLVANIA, UNITED STATES, August 23, 2024 /EINPresswire.com/ -- INDIGO Biosciences, a leading innovator in cell-based reporter assays, is excited to ...
Retex Pharmaceuticals Inc. has patented vasopressin V2 receptor antagonists potentially useful for the treatment of hyponatremia, cardiovascular disorders, autosomal dominant and autosomal recessive ...
Image of the mouse brain showing vasopressin-producing neurons (green) in the BNST region. In red, excitatory connections contacting these cells can be seen. The findings provide the first detailed ...
SIADH and diabetes insipidus, or arginine vasopressin disorder (AVD), involve opposite effects on the same hormone. AVD causes excessive urination and thirst, while SIADH leads to increased water ...
University of Miami has patented new vasopressin V1A receptor antagonists reported to be useful for the treatment of osteoporosis, Paget disease and cancer.
Modulation of the vasopressin pathway may be a promising new target for improving social and communication deficits in patients with autism spectrum disorder (ASD), new research suggests. Results from ...
Kyoto, Japan -- Jet lag is all in the mind. What exactly lags has more to do with the brain's hypothalamus than the jet. A misalignment of the body's internal clock following jet travel across ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results